Back

Excess atherosclerotic cardiovascular burden associated with elevated lipoprotein(a) across age, sex, and cardiometabolic risk factors: insights from 16-year follow-up of the HUNT Study

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids and cardiovascular risk (1) Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Youssef Khalil

Norwegian University of Science and Technology, Trondheim (Norway)

6 More presentations in this session

Presentation thumbnail
Intra-individual lipoprotein(a) variability and risk reclassification in patients with cardiovascular disease
Miss C. Zhang (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Higher liver fat content is associated with lower lipoprotein(a) concentrations in men and postmenopausal women
Doctor M. Markus (Greifswald, DE)
Abstract Slides Video
Presentation thumbnail
Determinants of lipoprotein(a) test utilization in Ontario following public reimbursement: a population-based analysis
Doctor L. Godoy (Ottawa, CA)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) associates with circulating annexin a1-positive extracellular vesicles linked to arterial calcification
Doctor P. Haider (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Ai-THERO Study: a population-based analysis of patients at high or very high risk of atherosclerotic cardiovascular disease and low-density lipoprotein cholesterol (LDL-C) levels in Cantabria, Spain
Doctor J. De La Torre Hernandez (Santander, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids and cardiovascular risk (1)

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein (a) cholesterol burden predicts atherosclerotic risk in patients with elevated lipoprotein a
13 April 2023
thumbnail
Congress Presentation
Sex-specific drug-target Mendelian randomisation on the effects of lipid-modifying targets on cardiovascular disease
4 April 2025
thumbnail
Congress Presentation
The distribution of lipoprotein(a) in Norway: a nationwide population-based study
27 August 2023
thumbnail
Congress Presentation
The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources